aluates Reports

$ 0.0

Automative

Global Duchenne Muscular Dystrophy Treatment Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-27D14102

Global Duchenne Muscular Dystrophy Treatment Market Research Report 2023

BUY CHAPTERS

Global Duchenne Muscular Dystrophy Treatment Market Research Report 2025

Code: QYRE-Auto-27D14102

Report

April 2025

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Italfarmaco SPA

FibroGen Inc

PTC Therapeutics

Santhera Pharmaceuticals

Sarepta Therapeutics Inc

Summit Therapeuticsplc

Duchenne Muscular Dystrophy Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Duchenne Muscular Dystrophy Treatment Market

The global market for Duchenne Muscular Dystrophy Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Duchenne Muscular Dystrophy Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Duchenne Muscular Dystrophy Treatment.

The Duchenne Muscular Dystrophy Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Duchenne Muscular Dystrophy Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Duchenne Muscular Dystrophy Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Duchenne Muscular Dystrophy Treatment Market Report

Report Metric	Details
Report Name	Duchenne Muscular Dystrophy Treatment Market
CAGR	5%
Segment by Type	NSAIDs Corticosteroids Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ITALFARMACO SpA, FibroGen, Inc., Summit Therapeuticsplc, PTC Therapeutics, Santhera Pharmaceuticals, Sarepta Therapeutics, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Duchenne Muscular Dystrophy Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Duchenne Muscular Dystrophy Treatment Market report?

Ans: The main players in the Duchenne Muscular Dystrophy Treatment Market are ITALFARMACO SpA, FibroGen, Inc., Summit Therapeuticsplc, PTC Therapeutics, Santhera Pharmaceuticals, Sarepta Therapeutics, Inc.

What are the Application segmentation covered in the Duchenne Muscular Dystrophy Treatment Market report?

Ans: The Applications covered in the Duchenne Muscular Dystrophy Treatment Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Duchenne Muscular Dystrophy Treatment Market report?

Ans: The Types covered in the Duchenne Muscular Dystrophy Treatment Market report are NSAIDs, Corticosteroids, Others

Recommended Reports

Neuromuscular Disorders

Rare Disease Therapies

Cardiometabolic & Chronic

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Duchenne Muscular Dystrophy Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 NSAIDs

1.2.3 Corticosteroids

1.2.4 Others

1.3 Market by Application

1.3.1 Global Duchenne Muscular Dystrophy Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Duchenne Muscular Dystrophy Treatment Market Perspective (2020-2031)

2.2 Global Duchenne Muscular Dystrophy Treatment Growth Trends by Region

2.2.1 Global Duchenne Muscular Dystrophy Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Duchenne Muscular Dystrophy Treatment Historic Market Size by Region (2020-2025)

2.2.3 Duchenne Muscular Dystrophy Treatment Forecasted Market Size by Region (2026-2031)

2.3 Duchenne Muscular Dystrophy Treatment Market Dynamics

2.3.1 Duchenne Muscular Dystrophy Treatment Industry Trends

2.3.2 Duchenne Muscular Dystrophy Treatment Market Drivers

2.3.3 Duchenne Muscular Dystrophy Treatment Market Challenges

2.3.4 Duchenne Muscular Dystrophy Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Duchenne Muscular Dystrophy Treatment Players by Revenue

3.1.1 Global Top Duchenne Muscular Dystrophy Treatment Players by Revenue (2020-2025)

3.1.2 Global Duchenne Muscular Dystrophy Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Duchenne Muscular Dystrophy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Duchenne Muscular Dystrophy Treatment Revenue

3.4 Global Duchenne Muscular Dystrophy Treatment Market Concentration Ratio

3.4.1 Global Duchenne Muscular Dystrophy Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Duchenne Muscular Dystrophy Treatment Revenue in 2024

3.5 Global Key Players of Duchenne Muscular Dystrophy Treatment Head office and Area Served

3.6 Global Key Players of Duchenne Muscular Dystrophy Treatment, Product and Application

3.7 Global Key Players of Duchenne Muscular Dystrophy Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Duchenne Muscular Dystrophy Treatment Breakdown Data by Type

4.1 Global Duchenne Muscular Dystrophy Treatment Historic Market Size by Type (2020-2025)

4.2 Global Duchenne Muscular Dystrophy Treatment Forecasted Market Size by Type (2026-2031)

5 Duchenne Muscular Dystrophy Treatment Breakdown Data by Application

5.1 Global Duchenne Muscular Dystrophy Treatment Historic Market Size by Application (2020-2025)

5.2 Global Duchenne Muscular Dystrophy Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Duchenne Muscular Dystrophy Treatment Market Size (2020-2031)

6.2 North America Duchenne Muscular Dystrophy Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Duchenne Muscular Dystrophy Treatment Market Size by Country (2020-2025)

6.4 North America Duchenne Muscular Dystrophy Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Duchenne Muscular Dystrophy Treatment Market Size (2020-2031)

7.2 Europe Duchenne Muscular Dystrophy Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Duchenne Muscular Dystrophy Treatment Market Size by Country (2020-2025)

7.4 Europe Duchenne Muscular Dystrophy Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Size (2020-2031)

8.2 Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Duchenne Muscular Dystrophy Treatment Market Size (2020-2031)

9.2 Latin America Duchenne Muscular Dystrophy Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Duchenne Muscular Dystrophy Treatment Market Size by Country (2020-2025)

9.4 Latin America Duchenne Muscular Dystrophy Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size (2020-2031)

10.2 Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 ITALFARMACO SpA

11.1.1 ITALFARMACO SpA Company Details

11.1.2 ITALFARMACO SpA Business Overview

11.1.3 ITALFARMACO SpA Duchenne Muscular Dystrophy Treatment Introduction

11.1.4 ITALFARMACO SpA Revenue in Duchenne Muscular Dystrophy Treatment Business (2020-2025)

11.1.5 ITALFARMACO SpA Recent Development

11.2 FibroGen, Inc.

11.2.1 FibroGen, Inc. Company Details

11.2.2 FibroGen, Inc. Business Overview

11.2.3 FibroGen, Inc. Duchenne Muscular Dystrophy Treatment Introduction

11.2.4 FibroGen, Inc. Revenue in Duchenne Muscular Dystrophy Treatment Business (2020-2025)

11.2.5 FibroGen, Inc. Recent Development

11.3 Summit Therapeuticsplc

11.3.1 Summit Therapeuticsplc Company Details

11.3.2 Summit Therapeuticsplc Business Overview

11.3.3 Summit Therapeuticsplc Duchenne Muscular Dystrophy Treatment Introduction

11.3.4 Summit Therapeuticsplc Revenue in Duchenne Muscular Dystrophy Treatment Business (2020-2025)

11.3.5 Summit Therapeuticsplc Recent Development

11.4 PTC Therapeutics

11.4.1 PTC Therapeutics Company Details

11.4.2 PTC Therapeutics Business Overview

11.4.3 PTC Therapeutics Duchenne Muscular Dystrophy Treatment Introduction

11.4.4 PTC Therapeutics Revenue in Duchenne Muscular Dystrophy Treatment Business (2020-2025)

11.4.5 PTC Therapeutics Recent Development

11.5 Santhera Pharmaceuticals

11.5.1 Santhera Pharmaceuticals Company Details

11.5.2 Santhera Pharmaceuticals Business Overview

11.5.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Treatment Introduction

11.5.4 Santhera Pharmaceuticals Revenue in Duchenne Muscular Dystrophy Treatment Business (2020-2025)

11.5.5 Santhera Pharmaceuticals Recent Development

11.6 Sarepta Therapeutics, Inc.

11.6.1 Sarepta Therapeutics, Inc. Company Details

11.6.2 Sarepta Therapeutics, Inc. Business Overview

11.6.3 Sarepta Therapeutics, Inc. Duchenne Muscular Dystrophy Treatment Introduction

11.6.4 Sarepta Therapeutics, Inc. Revenue in Duchenne Muscular Dystrophy Treatment Business (2020-2025)

11.6.5 Sarepta Therapeutics, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Italfarmaco SPA

FibroGen Inc

PTC Therapeutics

Santhera Pharmaceuticals

Sarepta Therapeutics Inc

Summit Therapeuticsplc

List of Tables

Table 1. Global Duchenne Muscular Dystrophy Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of NSAIDs

Table 3. Key Players of Corticosteroids

Table 4. Key Players of Others

Table 5. Global Duchenne Muscular Dystrophy Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Duchenne Muscular Dystrophy Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Duchenne Muscular Dystrophy Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Duchenne Muscular Dystrophy Treatment Market Share by Region (2020-2025)

Table 9. Global Duchenne Muscular Dystrophy Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Duchenne Muscular Dystrophy Treatment Market Share by Region (2026-2031)

Table 11. Duchenne Muscular Dystrophy Treatment Market Trends

Table 12. Duchenne Muscular Dystrophy Treatment Market Drivers

Table 13. Duchenne Muscular Dystrophy Treatment Market Challenges

Table 14. Duchenne Muscular Dystrophy Treatment Market Restraints

Table 15. Global Duchenne Muscular Dystrophy Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Duchenne Muscular Dystrophy Treatment Market Share by Players (2020-2025)

Table 17. Global Top Duchenne Muscular Dystrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Duchenne Muscular Dystrophy Treatment as of 2024)

Table 18. Ranking of Global Top Duchenne Muscular Dystrophy Treatment Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Duchenne Muscular Dystrophy Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Duchenne Muscular Dystrophy Treatment, Headquarters and Area Served

Table 21. Global Key Players of Duchenne Muscular Dystrophy Treatment, Product and Application

Table 22. Global Key Players of Duchenne Muscular Dystrophy Treatment, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Duchenne Muscular Dystrophy Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Duchenne Muscular Dystrophy Treatment Revenue Market Share by Type (2020-2025)

Table 26. Global Duchenne Muscular Dystrophy Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Duchenne Muscular Dystrophy Treatment Revenue Market Share by Type (2026-2031)

Table 28. Global Duchenne Muscular Dystrophy Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Duchenne Muscular Dystrophy Treatment Revenue Market Share by Application (2020-2025)

Table 30. Global Duchenne Muscular Dystrophy Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Duchenne Muscular Dystrophy Treatment Revenue Market Share by Application (2026-2031)

Table 32. North America Duchenne Muscular Dystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Duchenne Muscular Dystrophy Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Duchenne Muscular Dystrophy Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Duchenne Muscular Dystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Duchenne Muscular Dystrophy Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Duchenne Muscular Dystrophy Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Duchenne Muscular Dystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Duchenne Muscular Dystrophy Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Duchenne Muscular Dystrophy Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 47. ITALFARMACO SpA Company Details

Table 48. ITALFARMACO SpA Business Overview

Table 49. ITALFARMACO SpA Duchenne Muscular Dystrophy Treatment Product

Table 50. ITALFARMACO SpA Revenue in Duchenne Muscular Dystrophy Treatment Business (2020-2025) & (US$ Million)

Table 51. ITALFARMACO SpA Recent Development

Table 52. FibroGen, Inc. Company Details

Table 53. FibroGen, Inc. Business Overview

Table 54. FibroGen, Inc. Duchenne Muscular Dystrophy Treatment Product

Table 55. FibroGen, Inc. Revenue in Duchenne Muscular Dystrophy Treatment Business (2020-2025) & (US$ Million)

Table 56. FibroGen, Inc. Recent Development

Table 57. Summit Therapeuticsplc Company Details

Table 58. Summit Therapeuticsplc Business Overview

Table 59. Summit Therapeuticsplc Duchenne Muscular Dystrophy Treatment Product

Table 60. Summit Therapeuticsplc Revenue in Duchenne Muscular Dystrophy Treatment Business (2020-2025) & (US$ Million)

Table 61. Summit Therapeuticsplc Recent Development

Table 62. PTC Therapeutics Company Details

Table 63. PTC Therapeutics Business Overview

Table 64. PTC Therapeutics Duchenne Muscular Dystrophy Treatment Product

Table 65. PTC Therapeutics Revenue in Duchenne Muscular Dystrophy Treatment Business (2020-2025) & (US$ Million)

Table 66. PTC Therapeutics Recent Development

Table 67. Santhera Pharmaceuticals Company Details

Table 68. Santhera Pharmaceuticals Business Overview

Table 69. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Treatment Product

Table 70. Santhera Pharmaceuticals Revenue in Duchenne Muscular Dystrophy Treatment Business (2020-2025) & (US$ Million)

Table 71. Santhera Pharmaceuticals Recent Development

Table 72. Sarepta Therapeutics, Inc. Company Details

Table 73. Sarepta Therapeutics, Inc. Business Overview

Table 74. Sarepta Therapeutics, Inc. Duchenne Muscular Dystrophy Treatment Product

Table 75. Sarepta Therapeutics, Inc. Revenue in Duchenne Muscular Dystrophy Treatment Business (2020-2025) & (US$ Million)

Table 76. Sarepta Therapeutics, Inc. Recent Development

Table 77. Research Programs/Design for This Report

Table 78. Key Data Information from Secondary Sources

Table 79. Key Data Information from Primary Sources

Table 80. Authors List of This Report

List of Figures

Figure 1. Duchenne Muscular Dystrophy Treatment Picture

Figure 2. Global Duchenne Muscular Dystrophy Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Duchenne Muscular Dystrophy Treatment Market Share by Type: 2024 VS 2031

Figure 4. NSAIDs Features

Figure 5. Corticosteroids Features

Figure 6. Others Features

Figure 7. Global Duchenne Muscular Dystrophy Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Duchenne Muscular Dystrophy Treatment Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Others Case Studies

Figure 12. Duchenne Muscular Dystrophy Treatment Report Years Considered

Figure 13. Global Duchenne Muscular Dystrophy Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Duchenne Muscular Dystrophy Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Duchenne Muscular Dystrophy Treatment Market Share by Region: 2024 VS 2031

Figure 16. Global Duchenne Muscular Dystrophy Treatment Market Share by Players in 2024

Figure 17. Global Top Duchenne Muscular Dystrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Duchenne Muscular Dystrophy Treatment as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Duchenne Muscular Dystrophy Treatment Revenue in 2024

Figure 19. North America Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Duchenne Muscular Dystrophy Treatment Market Share by Country (2020-2031)

Figure 21. United States Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Duchenne Muscular Dystrophy Treatment Market Share by Country (2020-2031)

Figure 25. Germany Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Share by Region (2020-2031)

Figure 33. China Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Duchenne Muscular Dystrophy Treatment Market Share by Country (2020-2031)

Figure 41. Mexico Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Share by Country (2020-2031)

Figure 45. Turkey Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. ITALFARMACO SpA Revenue Growth Rate in Duchenne Muscular Dystrophy Treatment Business (2020-2025)

Figure 49. FibroGen, Inc. Revenue Growth Rate in Duchenne Muscular Dystrophy Treatment Business (2020-2025)

Figure 50. Summit Therapeuticsplc Revenue Growth Rate in Duchenne Muscular Dystrophy Treatment Business (2020-2025)

Figure 51. PTC Therapeutics Revenue Growth Rate in Duchenne Muscular Dystrophy Treatment Business (2020-2025)

Figure 52. Santhera Pharmaceuticals Revenue Growth Rate in Duchenne Muscular Dystrophy Treatment Business (2020-2025)

Figure 53. Sarepta Therapeutics, Inc. Revenue Growth Rate in Duchenne Muscular Dystrophy Treatment Business (2020-2025)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Becker Muscular Dystrophy Drug Market Research Report 2024

Retinal Dystrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Myotonic Dystrophy Type 1 DM1 Market Research Report 2025

Myotubular Myopathy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dystrophic Epidermolysis Bullosa Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Muscle Spasm Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Spinal Muscular Atrophy Medicine Market Research Report 2025

Skeletal Muscular Relaxants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Muscle Spasm Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dystrophic Epidermolysis Bullosa Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neurodegenerative Disease Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neurodegenerative Diseases Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Musculoskeletal Disorders Therapeutics Market Research Report 2025

Immune mediated Necrotizing Myopathy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Musculoskeletal Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Myocarditis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vulvodynia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Wilsons Disease Treatment Market Research Report 2024

RELATED REPORTS

Global Drug-Free Pain Management Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33I16356

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Adult Artificial Heart Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32W16534

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Viral Vector Vaccine for Humans Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23Z16367

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Cardioplegia Adapter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33A16598

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions